Results 101 to 110 of about 8,412,631 (306)

Portal hypertension is associated with modulation of regulatory T cells

European Journal of Inflammation, 2016
Background: Portal hypertension is a complication of liver cirrhosis. The portal vein drains the spleen and the intestines, which are both rich in inflammatory mediators.
Tomer Adar, Yair Edden, Shimon Shteingart, Ami Ben Ya’acov, Mahmud Mahamid, Ellen Broide, Shimrit Shmorak, Ariella Bar-Gil Shitrit, Constantin Reinus, Eran Goldin   +9 more
doaj   +1 more source

Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study

Pulmonary Circulation, 2020
Patients with portal hypertension may develop pulmonary hypertension. The economic implications of these comorbidities have not been systematically assessed. We compared healthcare resource utilization and costs in the United States between patients with
Sandeep Sahay, Yuen Tsang, Megan Flynn, Peter Agron, Robert Dufour   +4 more
doaj   +1 more source

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation

Liver Transplantation, EarlyView., 2022
Abstract Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplantation (LT) candidates. Children with HPS are granted Model for End‐Stage Liver Disease (MELD)/Pediatric End‐Stage Liver Disease (PELD) exception points for waitlist prioritization in the United States based on criterion developed for adults.
Muhammad H. Raza, Yong Kwon, Pierre Kobierski, Asish C. Misra, Angelina Lim, Cameron Goldbeck, Kambiz Etesami, Rohit Kohli, Juliet Emamaullee   +8 more
wiley   +1 more source

Prevalence of hypertension in low- and middle-income countries [PDF]

, 2015
We aimed to obtain overall and regional estimates of hypertension prevalence, and to examine the pattern of this disease condition across different socio-demographic characteristics in low-and middle-income countries.We searched electronic databases from
Sarki, Ahmed M., Kandala, Ngianga-Bakwin, Sarki, Ahmed, Uthman, Olalekan, Nduka, Chidozie U., Uthman, Olalekan A., Sarki, Ahmed M, Nduka, Chidozie U, Stranges, Saverio, Nduka, Chidozie   +9 more
core   +1 more source

Evaluation of liver stiffness measurement–based scores in liver transplantation recipients

Liver Transplantation, EarlyView., 2022
Abstract Combining bioclinical parameters with liver stiffness measurement (LSM) has improved the diagnostic performance of vibration‐controlled transient elastography (VCTE) for detection of advanced fibrosis in patients with chronic liver disease. However, this approach has not yet been tested in liver transplantation (LT) recipients.
Tamoore Arshad, Chandra S. Bhati, Anh T. Bui, Michael Tseng, Dylan Vainer, Austin Miller, Marie‐Claire Evans, Taseen Syed, Vaishali Patel, Michael O. Idowu, Mark Muthiah, Mohammad Shadab Siddiqui   +11 more
wiley   +1 more source

Pharmacological Management of Portal Hypertension: A Review Article [PDF]

Zagazig University Medical Journal
Background: Portal Hypertension is considered an abnormal elevation of pressure in the veins that drain blood from the visceral organs (e.g., the spleen) to the liver.
Mennatullah ELnaggar, Sohair El-Menshawy, Fatma Shehata, Nevertyty Mahmoud   +3 more
doaj   +1 more source

portal hypertension

, 2004
Portal hypertension is a common syndrome with serious clinical consequences. Some aspects of pathophysiology, causes and clinical features are discussed.
Martinelli, Ana L. Candolo
core   +1 more source

Portopulmonary hypertension practice patterns after liver transplantation

Liver Transplantation, EarlyView., 2022
Abstract Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...
Arun Jose, Elizabeth J. Kopras, Shimul A. Shah, Jean M. Elwing   +3 more
wiley   +1 more source

Percutaneous transhepatic portal vein stenting in a patient with benign non-transplant postoperative portal vein stenosis: A case report

Indian Journal of Radiology and Imaging, 2013
Extrahepatic portal vein stenosis is caused by a variety of benign and malignant diseases and results in development of symptoms due to portal hypertension.
KS Madhusudhan, Nikhil Agrawal, Deep N Srivastava, Sujoy Pal, Arun K Gupta   +4 more
doaj   +1 more source

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension

, 2009
BACKGROUND/AIMS: Angiogenesis is a pathological hallmark of portal hypertension. Although VEGF is considered to be the most important proangiogenic factor in neoangiogenesis, this process requires the coordinated action of a variety of factors ...
Berzigotti, Annalisa, de Gottardi, Andrea, Tiani, Carolina, Bosch, Jaime, Fernandez, Mercedes, Garcia-Pras, Ester, Mejias, Marc   +6 more
core   +1 more source